SELLAS Life Sciences Group Investor Relations Material
Latest events
Study Update
SELLAS Life Sciences Group
Q2 2025
12 Aug, 2025
Q1 2025
13 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from SELLAS Life Sciences Group Inc
Access all reports
SELLAS Life Sciences Group Inc. is a biopharmaceutical company focused on developing immunotherapies for cancer. The company specializes in targeted peptide-based therapies designed to stimulate the immune system against various tumor types. Its research and development efforts aim to advance novel cancer treatments through clinical trials and regulatory approvals. The company is headquartered in Montvale, New Jersey, and its shares are listed on the NASDAQ.
)
)
)